Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 91.1 CHF 2.94% Market Closed
Market Cap: 1.2B CHF

Medartis Holding AG
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medartis Holding AG
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Medartis Holding AG
SIX:MED
Operating Income
CHf12.8m
CAGR 3-Years
27%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
Operating Income
$1.4B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Operating Income
CHf21.4m
CAGR 3-Years
-15%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Operating Income
CHf224m
CAGR 3-Years
81%
CAGR 5-Years
89%
CAGR 10-Years
20%
IVF Hartmann Holding AG
SIX:VBSN
Operating Income
CHf22.1m
CAGR 3-Years
35%
CAGR 5-Years
6%
CAGR 10-Years
1%
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
1.1B CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
93.3 CHF
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Medartis Holding AG's Operating Income?
Operating Income
12.8m CHF

Based on the financial report for Jun 30, 2025, Medartis Holding AG's Operating Income amounts to 12.8m CHF.

What is Medartis Holding AG's Operating Income growth rate?
Operating Income CAGR 5Y
31%

Over the last year, the Operating Income growth was 55%. The average annual Operating Income growth rates for Medartis Holding AG have been 27% over the past three years , 31% over the past five years .

Back to Top